LISBON NOV 14-15 2018

CSO & Founder Prof. Dr. F. Wurm will be the keynote speaker in the Optimizing Expression Platforms conference at PEGS Summit Europe taking place in Lisbon, Portugal on the 14-15 November 2018. The topic: Transient Protein (Gene) Expression: From R&D towards Pharmaceutical Manufacturing. The Cambridge Health Institute and Prof. Wurm discuss foreseeable advances in transient protein expression for the next decade.

NEWS

Transient Gene Expression for Rapid Protein Supply is the topic of an upcoming Special Issue in Processes, an open access journal of chemical and biological process engineering.

Research in this field aims to reduce the cost and time needed to produce proteins of value for academia and industry. In view of this, Dr. Florian Wurm and Dr. Martin Jordan of Merck Biopharma in Switzerland have agreed to be guest editors.

LISBON 20-22 MARCH 2018

Prof. F. Wurm provided a keynote lecture: CHO: Optimizing Cell Culture Technologies for Manufacturing of Recombinant Proteins – Past, Presence and Future at the Bioprocessing Summit Europe conference in Lisbon on March 20th.

Dr. Maria Wurm, CEO of ExcellGene provided a seminar on Bioreactor-Based Optimization and Scale-up Issues for Large Scale Manufacture with Suspension Cultures of Animal Cells, on March 22.

NEWS

In an article written in November 2017 by Dr. Angelo DePalma in Genetic Engineering and Biotechnology News (GEN), ExcellGene and Prof. F. Wurm were referred to discussing the benefits of better media and feeds as the main driver for the higher yields from CHO cells and the processes developed for large scale manufacturing. This conclusion is based on more than 3 decades of observation and analysis of CHO cells for manufacturing purposes…